2022. Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective. Biomolecules and Biomedicine. 22, 5 (Sep. 2022), 699–706. DOI:https://doi.org/10.17305/bjbms.2021.7326.